Published by
Reuters
Reuters
TEL AVIV (Reuters) – A third dose of Pfizer/BioNTech’s COVID-19 vaccine was found to be 86% effective in people aged over 60, an Israeli healthcare provider said on Wednesday, citing initial results from a study of thousands of members. Israeli HMO Maccabi, which covers around a quarter of the country’s 9.3 million population, compared results from 149,144 people aged over 60 who received their third dose at least a week ago against those from 675,630 more who had received only two doses, between January and February. Some 37 people tested positive for coronavirus after their third jab, compar…